| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/21/1993 | EP0343248B1 Novel polypeptide and method for preparing the same |
| 04/21/1993 | EP0298121B1 Biocompatible material for treatment of defects in tissues and organs |
| 04/21/1993 | CN1071164A 含氮杂环化合物 Nitrogen-containing heterocyclic compounds |
| 04/20/1993 | US5204364 N-imidazolyl- and n-imidazolylmethyl-derivatives of substituted bicyclic compounds |
| 04/20/1993 | US5204357 Enzyme inhibitors |
| 04/20/1993 | US5204355 Reducing or inhibitory effect on cerebral edema, antihypoxic agent |
| 04/20/1993 | US5204351 Antiarteriosclerosis, anticholesterol agents |
| 04/20/1993 | US5204350 Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
| 04/20/1993 | US5204346 Pyrazolopyridine compounds |
| 04/20/1993 | US5204338 Oxalylamino acid derivatives and their use as medicaments for inhibiting proline hydroxylase |
| 04/20/1993 | US5204334 Inhibition of calcium resorption; osteoporosis; Paget's disease; bone disorders |
| 04/20/1993 | CA1316630C Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides |
| 04/19/1993 | EP0607124A4 Alteration of rate and character of hair growth. |
| 04/18/1993 | CA2080618A1 Mrsa active 2-halophenyl-carbapenems |
| 04/18/1993 | CA2080617A1 Mrsa active 2-phenyl-carbapenems |
| 04/15/1993 | WO1993007429A1 Air treatment plant for foodstuff comprising a trough with an adjustable width |
| 04/15/1993 | WO1993007148A1 Novel potent inducers of terminal differentiation and methods of use thereof |
| 04/15/1993 | WO1993007147A1 3,9-diazabicyclo(3.3.1)nonane derivatives with 5-ht3 receptor antagonist activity |
| 04/15/1993 | WO1993007146A1 Benzo and pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity |
| 04/15/1993 | WO1993007124A1 Nitrogenous heterocyclic compound |
| 04/15/1993 | WO1993007109A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phtalazineacetic acids and derivatives, preparations thereof and drugs containing same |
| 04/15/1993 | WO1993006872A1 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
| 04/15/1993 | WO1993006853A1 Cell damage repairing factor |
| 04/15/1993 | WO1993006852A2 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 04/15/1993 | WO1993006845A1 PARATHYROID HORMONE ANALOGUES SUBSTITUTED AT aa?25,26,27¿ AND USE IN OSTEOPOROSIS TREATMENT |
| 04/15/1993 | WO1993006791A1 Collagen constructs |
| 04/15/1993 | WO1993004710A3 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
| 04/15/1993 | WO1992020328A3 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 04/15/1993 | CA2120946A1 Parathyroid hormone analogues substituted at aa 25.26.27 and use in osteoporosis treatment |
| 04/15/1993 | CA2120606A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phthalazineacetic acids and derivatives, preparations thereof and drugs containing same |
| 04/15/1993 | CA2116336A1 Nitrogenous heterocyclic compound |
| 04/15/1993 | CA2079414A1 Heterocyclic compounds |
| 04/14/1993 | EP0536817A1 Azabicyclic compounds as tachykinin antagonists |
| 04/14/1993 | EP0536310A1 Chemical compounds |
| 04/14/1993 | EP0536299A1 Surface complexed lymphotoxin |
| 04/14/1993 | EP0536295A1 Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands |
| 04/14/1993 | EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/14/1993 | EP0536262A1 Substituted histidines |
| 04/14/1993 | EP0536186A1 Bone and cartilage inductive proteins |
| 04/13/1993 | US5202456 Anticarcinogenic agents; methylating transferase inhibitors; farnesyl or geranyl sulfur-, oxygen or selenium-containing derivatives |
| 04/13/1993 | US5202351 Treating hyperlipemia, atherosclerosis |
| 04/13/1993 | US5202349 Substituted phenylacetylenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions |
| 04/13/1993 | US5202344 N-substituted lactams useful as cholecystokinin antagonists |
| 04/13/1993 | US5202334 Pyrazolo[1,5-a]pyridine compounds, and production and use thereof |
| 04/13/1993 | US5202328 Substituted fused pyrimidinones |
| 04/13/1993 | US5202321 Antihistamine, antiallergens, antiinflammatory agents |
| 04/13/1993 | US5202317 Synthetic drug molecules that mimic metalloenzymes |
| 04/13/1993 | US5202314 10-thioethyl-steroids |
| 04/13/1993 | CA1316132C Cdna and gene for human angiogenin (angiogenesis factor) and method of expression |
| 04/10/1993 | CA2080054A1 17beta-substituted aza-androstane derivatives |
| 04/08/1993 | CA2079982A1 Substituted pyrazino (2,3-d)-pyrimidinones as angiotensin ii antagonists |
| 04/08/1993 | CA2079770A1 Angiotensin ii antagonists incorporating a substituted 1, 3-benzodioxole and 1, 3-benzodithiole |
| 04/07/1993 | EP0535926A1 (Hetero-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535925A1 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535923A1 (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535740A1 Respiratory disease vaccine for cats |
| 04/07/1993 | EP0535548A1 Inhibitor of atherosclerotic intimal thickening |
| 04/07/1993 | EP0535545A1 Artificial tears containing oil and wax |
| 04/07/1993 | EP0535420A1 Imidazol-5-carbon acid derivatives acylales as angiotensin II inhibitors |
| 04/07/1993 | EP0535336A2 MK protein as cell growth inhibitor |
| 04/07/1993 | EP0535148A1 Stimulation of bone marrow stromal and progenitor cells |
| 04/07/1993 | EP0535092A1 Protease nexin-i variants |
| 04/07/1993 | EP0534978A1 Interleukin-1 antagonist and uses thereof |
| 04/07/1993 | EP0532674A4 Leukotriene antagonists |
| 04/07/1993 | EP0491849A4 A method for the purification of transforming growth factor (tgf-) |
| 04/07/1993 | EP0366728B1 Polypeptides with fibronectin activity |
| 04/07/1993 | EP0215110B1 Production of human somatomedin c |
| 04/06/1993 | US5200417 Substituted 4-amino-isoquinoline compounds, pharmaceutical composition and method of use |
| 04/06/1993 | US5200416 Cyclic amides |
| 04/06/1993 | US5200412 Antiinflammatory agents and antiallergens |
| 04/06/1993 | US5200405 Use of n-(1-hexahydroazepinylalkyl) acetamides for the treatment of cholinergic transmission disorders |
| 04/06/1993 | US5200397 Administering an oligopeptides anticoagulants or wound healing agents |
| 04/06/1993 | US5200342 Squalene synthetase inhibitors and processes therefrom |
| 04/06/1993 | CA1315717C Nucleic acid derivatives |
| 04/06/1993 | CA1315690C Synergistic combination of decarboxylase inhibitors and l-dopa pellets |
| 04/06/1993 | CA1315684C Anti-retroviral agents and delivery system for the same |
| 04/05/1993 | WO1993006823A1 Verbenone, having antielastase activity, against pulmonary emphysema |
| 04/05/1993 | CA2097611A1 Verbenone, having antielastase actibity, against pulmonary emphysema |
| 04/05/1993 | CA2079735A1 Acylals of imidazole-5-carboxylic acid derivatives, process for their preparation and their use |
| 04/03/1993 | CA2079658A1 Dry eye treatment process and solution |
| 04/01/1993 | WO1993006223A1 Viral recombinant vectors for expression in muscle cells |
| 04/01/1993 | WO1993006105A1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 04/01/1993 | WO1993006092A1 Piperazinyl (sulfonyl)amide derivatives of camphor as oxytocin antagonists |
| 04/01/1993 | WO1993006085A1 Pyridine compounds for treating leukotriene-related diseases |
| 04/01/1993 | WO1993005823A1 Bone-growth-stimulating composition |
| 04/01/1993 | WO1993005809A1 Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation |
| 04/01/1993 | WO1993005808A1 Bone-growth-stimulating composition |
| 04/01/1993 | WO1993005795A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds |
| 04/01/1993 | WO1993005781A1 Novel alpha-mannosidase inhibitors |
| 04/01/1993 | WO1993005779A1 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases |
| 04/01/1993 | WO1993005751A2 Osteogenic proteins in the treatment of bone deseases |
| 04/01/1993 | WO1993001286A3 Localized oligonucleotide therapy |
| 04/01/1993 | CA2119467A1 Pyridine compounds for treating leukotriene-related diseases |
| 04/01/1993 | CA2119019A1 Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation |
| 03/31/1993 | EP0534856A1 Oxime ethers of thienocyclopentanones, their preparation and pharmaceutical compositions containing them |
| 03/31/1993 | EP0534706A1 Quinazolinones and pyridopyrimidinones useful as angiotensin II antagonists |
| 03/31/1993 | EP0534568A2 Human growth hormone analogues and their use |
| 03/31/1993 | EP0534511A1 HIV protease inhibitors useful for the treatment of aids |
| 03/31/1993 | EP0534492A2 Carboxyalkyl substituted inhibitors of enkephalinase and ACE |
| 03/31/1993 | EP0534445A1 Process for the preparation of a medicament for oral or topical administration in the treatment of leishmaniasis |